Belladonna And Opium Suppository
NDC Package 0574-7045-04
Package Information
Belladonna And Opium (atropa belladonna and opium) suppositories is belladonna and opium suppositories are used for relief of moderate to severe pain associated with ureteral spasm not responsive to non-narcotic analgesics and to space intervals between injections of opiates. This formulation utilizes a suppository delivery system. Marketed by Padagis Us Llc, this product is identified by NDC 0574-7045.
Identification & Billing
- RxCUI: 312104 - belladonna 16.2 MG / opium 30 MG Rectal Suppository
- RxCUI: 312104 - belladonna alkaloids 16.2 MG / opium 30 MG Rectal Suppository
- RxCUI: 312107 - belladonna 16.2 MG / opium 60 MG Rectal Suppository
- RxCUI: 312107 - belladonna alkaloids 16.2 MG / opium 60 MG Rectal Suppository
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0574 - Padagis Us Llc
- 0574-7045 - Belladonna And Opium
- 0574-7045-04 - 4 PACKET in 1 BOX / 1 SUPPOSITORY in 1 PACKET
- 0574-7045 - Belladonna And Opium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0574-7045). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0574-7045-04 identifies a specific commercial package of 4 packet in 1 box / 1 suppository in 1 packet of Belladonna And Opium, a human prescription drug labeled by Padagis Us Llc. This suppository is formulated for rectal use and contains atropa belladonna; opium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Padagis Us Llc on May 01, 1994. The current certification is valid through December 31, 2026.
How is this Padagis Us Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00574704504. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 4 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.